Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations-Reference-Cited by-同舟云学术

Improved metastasis-free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

Published:2014-05-20 Issue:1 Volume:136 Page:91-97
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Span P.N.¹,Pollakis G.²³,Paxton W.A.²³,Sweep F.C.G.J.⁴,Foekens J.A.⁵,Martens J.W.M.⁵,Sieuwerts A.M.⁵,van Laarhoven H.W.M.⁶

Affiliation:

1. Department of Radiation Oncology; Radboud University Medical Center; Nijmegen The Netherlands

2. Laboratory of Experimental Virology; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

3. Department of Clinical Infection Microbiology and Immunology; IGH, University of Liverpool; Liverpool United Kingdom

4. Department of Laboratory Medicine; Radboud University Medical Center; Nijmegen The Netherlands

5. Department of Medical Oncology; Erasmus MC Cancer Institute, Erasmus University Medical Center, and Cancer Genomics Netherlands; Rotterdam The Netherlands

6. Department of Medical Oncology; Academic Medical Center, University of Amsterdam; Amsterdam The Netherlands

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

BBMRI-NL

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

2. Using multigene tests to select treatment for early-stage breast cancer;Goncalves;J Natl Compr Canc Netw,2013

3. The inflammatory chemokine CCL5 and cancer progression;Aldinucci;Mediat Inflamm,2014

4. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia;Lin;Cancer Sci,2012

5. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection;Liu;Cell,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role and Therapeutic Targeting of CCR5 in Breast Cancer;Cells;2023-09-08

2. CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome;Breast Cancer Research;2022-05-23

3. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population;Frontiers in Immunology;2021-12-10

4. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment;Molecular Biology Reports;2019-11-05

5. Chemokines in breast cancer: Regulating metabolism;Cytokine;2018-09